Lets more drugs for rare diseases get approved for different specific uses.
This bill would let more drugs for rare diseases get approved for different specific uses. Currently, one drug can block others for an entire rare disease. This change would allow more treatment options to become available sooner by narrowing that protection.
Today, a drug approved for a rare disease gets 7 years of market protection, blocking other drugs for the entire "same disease or condition." If this bill becomes law, that 7-year protection would only apply to the "same approved use or indication" within that rare disease. This would allow the Food and Drug Administration to approve other drugs for different specific uses within the same rare disease.
S 3716 · 119th Congress · January 28, 2026 · AI Summary by gemini-2.5-flash · 9/10
Sign in to see your representatives' phone numbers